Kangdong Liu
Chinese Center For Disease Control and Prevention(CN)TEDA International Cardiovascular Hospital(CN)Prevention Institute(US)Zhengzhou University(CN)Eastern Cooperative Oncology Group(US)Henan Tianguan Group (China)(CN)Henan Academy of Sciences(CN)Ministry of Education(IR)China-US (Henan) Hormel Cancer Institute(CN)Henan Cancer Hospital(CN)Henan Provincial Center for Disease Control and Prevention(CN)
Publications by Year
Research Areas
Cancer-related Molecular Pathways, Melanoma and MAPK Pathways, Cancer, Lipids, and Metabolism, RNA modifications and cancer, Flavonoids in Medical Research
Most-Cited Works
- → Targeting AURKA in Cancer: molecular mechanisms and opportunities for Cancer therapy(2021)601 cited
- → Unraveling the complexity of STAT3 in cancer: molecular understanding and drug discovery(2024)185 cited
- → Integrins in cancer: Emerging mechanisms and therapeutic opportunities(2023)160 cited
- → Protein translation: biological processes and therapeutic strategies for human diseases(2024)107 cited
- → Targeting CDK12 for Cancer Therapy: Function, Mechanism, and Drug Discovery(2020)94 cited
- → Erianin suppresses constitutive activation of MAPK signaling pathway by inhibition of CRAF and MEK1/2(2023)89 cited